Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT05412446What this trial is testing99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph NodesWho this might be right forBreast CancerFemale Tomsk National Research Medical Center of the Russian Academy of Sciences 30
Testing effectiveness (Phase 2)Study completedNCT04592484What this trial is testingA First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid TumorsWho this might be right forAdvanced Solid Tumor Codiak BioSciences 27
Early research (Phase 1)Ended earlyNCT00634088What this trial is testingPhase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerWho this might be right forLocally Advanced or Metastatic Breast Cancer R-Pharm 13
Early research (Phase 1)Study completedNCT03451162What this trial is testingSafety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 14
Not applicableLooking for participantsNCT06781281What this trial is testingNabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.Who this might be right forBreast Cancer Invasive Henan Cancer Hospital 709
Testing effectiveness (Phase 2)Study completedNCT01138384What this trial is testingStudy of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer NCIC Clinical Trials Group 19
Testing effectiveness (Phase 2)Study completedNCT04420598What this trial is testingDS-8201a for trEatment of aBc, BRain Mets, And Her2[+] DiseaseWho this might be right forAdvanced Breast CancerHER2-positive Breast CancerBrain Metastases+1 more MedSIR 41
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Testing effectiveness (Phase 2)Ended earlyNCT01185509What this trial is testingTrastuzumab and Vinorelbine in Advanced Breast CancerWho this might be right forBreast CancerMetastatic Breast Cancer Dana-Farber Cancer Institute 31
Early research (Phase 1)Looking for participantsNCT07029399What this trial is testingA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forHR+ Breast CancerTriple Negative Breast Cancer (TNBC)CCNE1 Amplified Advanced Solid Tumors+1 more NiKang Therapeutics, Inc. 361
Early research (Phase 1)Study completedNCT04818632What this trial is testingAZD9833 China PK StudyWho this might be right forER+, HER2-, Metastatic Breast Cancer AstraZeneca 28
Not applicableStudy completedNCT07086196What this trial is testingReal-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast CancerWho this might be right forMetastatic HR+/HER2- Breast Cancer Novartis Pharmaceuticals 350
Early research (Phase 1)Active Not RecruitingNCT05870579What this trial is testing[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Looking for participantsNCT05377996What this trial is testingEmiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsWho this might be right forTriple Negative Breast CancerBreast CancerEndometrial Cancer+4 more Day One Biopharmaceuticals, Inc. 360
Testing effectiveness (Phase 2)Study completedNCT00633750What this trial is testingErlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center 50
Not applicableLooking for participantsNCT05460780What this trial is testingFirst-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for CancerWho this might be right forBreast Cancer FemaleBreast Cancer PreventBreast Reconstruction Quanta Medical 50
Early research (Phase 1)Looking for participantsNCT05627960What this trial is testingFirst in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesWho this might be right forTriple Negative Breast CancerHormone-Resistant Breast CancerNon Small Cell Lung Cancer+1 more A&G Pharmaceutical Inc. 77
Not applicableStudy completedNCT02023359What this trial is testingDanish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast CancerWho this might be right forBreast Cancer Novartis Healthcare A/S 7
Early research (Phase 1)Looking for participantsNCT06756932What this trial is testingBGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast CancerWho this might be right forHormone-receptor-positive Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer BeOne Medicines 120